title: [Biotransformation in vivo/vitro and bioactive properties of rare ginsenoside IH901].
abstract: Recent metabolomics research revealed a new ginseng ginsenoside IH901 that is synthesized by intestinal microbial transformation in oral administration of ginseng. IH901 shows various biological activities, including anti-tumor, anti-inflammatory, anti-diabetic, and anti-aging. In recent years, great effort has been made to prepare IH901 by microbial and enzymatic transformation in a large scale. In this paper, we reviewed the biotransformation pathways both in vivo and in vitro and bioactive properties of rare ginsenoside IH901.
authors.affiliation: College of Chemical Engineering, Huaqiao University, Xiamen 361021, Fujian, China.
authors.forename: Yuxing
authors.initials: Y
authors.lastname: Tong
authors.forename: Zhizhong
authors.initials: Z
authors.lastname: Zheng
authors.forename: Qingxuan
authors.initials: Q
authors.lastname: Tong
authors.forename: Yi
authors.initials: Y
authors.lastname: Lin
authors.forename: Yanlin
authors.initials: Y
authors.lastname: Ming
mesh_terms: D001711:Biotransformation; D036145:Ginsenosides / Q000378:metabolism* / Q000493:pharmacokinetics*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000382:microbiology; D005894:Panax / Q000737:chemistry*; D012502:Sapogenins / Q000378:metabolism*
chemical_list: C482402:20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol; D036145:Ginsenosides; D012502:Sapogenins